Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Surgical Oncology

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jso.21383PMID 19722231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thymidylate synthase genotyping is more predictive for therapy response than immunohistochemistry in patients with colon cancer

  2008cited by this paper
• Adjuvant Treatment of Colon Cancer: Past, Present and Future

  2007cited by this paper
• The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5‐fluorouracil

  2007influential reference
• Population Screening for Colorectal Cancer: Faeces, Endoscopes or X-Rays?

  2007cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Expression of Thymidylate Synthase in Primary Colorectal Adenocarcinoma

  2006cited by this paper
• Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer.

  2006cited by this paper
• Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.

  2005cited by this paper
• Thymidylate synthase structure, function and implication in drug discovery.

  2005cited by this paper
• Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity.

  2005cited by this paper
• Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer

  2005cited by this paper
• Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil

  2005cited by this paper
• Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue.

  2005cited by this paper
• Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis.

  2004cited by this paper
• Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review

  2004cited by this paper
• A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels.

  2004cited by this paper
• Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma

  2003cited by this paper
• Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?

  2003cited by this paper
• Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.

  2003influential reference
• Significance of Thymidylate Synthase Expression in Colorectal Cancer

  2002cited by this paper
• Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.

  2002cited by this paper
• Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.

  2002cited by this paper
• Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer.

  2002cited by this paper
• Clinical significance of prognostic and predictive markers in colorectal cancer

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene.

  2000cited by this paper
• Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations.

  1999cited by this paper
• Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

  1991cited by this paper
• An isotopic assay for thymidylate synthetase.

  1966cited by this paper

• Identification of LncRNAs Associated With FOLFOX Chemoresistance in mCRC and Construction of a Predictive Model

  2021cites this paper
• FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

  2020cites this paper
• Methionine synthase A2756G polymorphism associated with an increased risk of head and neck cancer

  2020cites this paper
• Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancer

  2017cites this paper
• Folates in the Treatment of Colorectal Cancer

  2015cites this paper
• Dynamic Modulation of Thymidylate Synthase Gene Expression and Fluorouracil Sensitivity in Human Colorectal Cancer Cells

  2015cites this paper
• Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal Cancer

  2014cites this paper
• Gene profiling and bioinformatics analyses reveal time course differential gene expression in surgically resected colorectal tissues

  2014influential citation
• Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer

  2013cites this paper
• An integrated analysis of the association between Ts gene polymorphisms and clinical outcome in gastric and colorectal cancer patients treated with 5-FU-based regimens

  2013cites this paper
• Establishment of a Predictive Genetic Model for Estimating Chemotherapy Sensitivity of Colorectal Cancer with Synchronous Liver Metastasis

  2013cites this paper
• Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Meta-Analysis of Colorectal Cancer Survival Data

  2012cites this paper
• UGT1A1 predicts outcome in colorectal cancer treated with irinotecan and fluorouracil.

  2012cites this paper
• Gene polymorphisms MTHFRC677T and MTRA2756G as predictive factors in adjuvant chemotherapy for stage III colorectal cancer.

  2011cites this paper
• Gene Polymorphisms MTHFR C 677 T and MTR A 2756 G as Predictive Factors in Adjuvant Chemotherapy for Stage III Colorectal Cancer

  2011cites this paper
• Association of MTR A 2756 G Gene Polymorphism with Risk of Head and Neck Cancer

  year unknowncites this paper